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phe gold standard for mediastinal lymph node staging is
mediastinoscopy. Standard mediastinoscopy or video
ediastinoscopy provides access to levels 2R, 2L, 7, 4R, 4L,
nd 10 lymph nodes. Standard mediastinoscopy helps con-
rm the presence of malignant disease in clinically suspicious
ymph nodes and is reliable for diagnosing occult microscopic
isease for the adequate staging of lung cancer. Endobronchial
ltrasound-guided transbronchial needle aspiration (EBUS-
BNA) has provided an alternative to mediastinoscopy for the
iopsy ofmediastinal lymphnodes in select clinical situations as
ell as provided access to more peripheral nodes and nodules
hat mediastinoscopy cannot access.
Mediastinoscopy is considered a very safe procedure with
reported operative mortality of 0.05 to 0.2% in a large series
f patients with a complication rate of 0.56 to 1.07%.1,2 Re-
orted complications include hemorrhage, vocal cord injury,
racheal injury, and pneumothorax. A large series of EBUS-
BNA have reported no mortality and almost no morbidity
ssociated with the procedure.3-5 Furthermore, preliminary
tudies have reported sensitivity of EBUS-TBNA in identify-
ng nodal metastases in the setting of lung cancer ranging
rom 90 to 98%, depending on the population studied.4-7
nesthesia
everal options are available for anesthesia during EBUS.
onscious sedation with short-acting agents such as fentanyl
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oi:10.1053/j.optechstcvs.2009.04.001nd midazolam may be utilized in an ambulatory setting to
erform EBUS. Given the larger size of the EBUS videobron-
hoscope, it is generally passed transorally rather than via the
tandard transnasal approach. Predominant intravenous an-
sthesia with propofol and fentanyl can also be utilized in
oncert with a laryngeal mask airway device for adequate
ontrol of the airway. The tip of the scope can comfortably fit
hrough a no. 4 laryngeal mask. The procedure can also safely
e performed under general anesthesia using a no. 8.5 or
arger endotracheal tube. The videobronchoscope can fit
hrough a no. 8 endotracheal tube as well but a larger tube
llows for better ventilation. The laryngeal mask airway does
rovide the advantage of allowing for visualization of the
ntire paratracheal area. If using an endotracheal tube, the
ube may need to be withdrawn to a point near the vocal
ords to allow for ultrasound visualization of the high para-
racheal lymph nodes. We typically prefer general anesthesia
iven the time required to perform multiple biopsies at mul-
iple different nodal stations. Bronchoscopy is performed
ith a conventional flexible bronchoscope before EBUS to
dequately assess the airway for intrabronchial tumor, mu-
osal abnormalities, and endotracheal tube positioning in the
roximal trachea.
During the procedure, a cytopathology technician is
resent in the operating room to help prepare the slides. An
n-site cytopathologist greatly facilitates the process by al-
owing for immediate assessment of the adequacy of and
iagnostic evaluation of the specimen. This is of critical im-
ortance if EBUS-TBNA is to be utilized to make intraopera-
ive decisions as is currently done with mediastinoscopy. The
resence of lymph tissue is often considered an adequate
pecimen.
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100 T.D. CrabtreeOperative Technique
Figure 1 The linear array ultrasonic bronchoscope (Olympus XBF-UC 160F) with the biopsy sheath deployed. The
outer diameter of the EBUS scope is 6.7 mm and 6.9 mm at the tip. The optical system in this scope provides an
80-degree field of view at a 35-degree forward oblique angle. The EBUS scope provides monocolor Doppler flow
mapping for identification of blood vessels. (Color version of figure is available online at http://www.optechtcs.com.)
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Endobronchial ultrasound 101igure 2 Mediastinal and hilar lymph nodes. (A) High-
ighted nodes are typically accessible by standard cervical
ideo mediastinoscopy. (B) Highlighted nodes are typi-
ally accessible by EBUS-TBNA. a.  artery; Ao  aorta;
A pulmonary artery; pulm lig pulmonary ligament;
.  vein.
102 T.D. CrabtreeFigure 3 EBUS-TBNA of subcarinal
(station 7) lymph nodes. (A) The
EBUS scope can be positioned in ei-
ther the proximal right mainstem
bronchus (as depicted) or the proxi-
mal left mainstem bronchus. (B) The
scope is positioned in the right main-
stem bronchus with the balloon in-
flated. Pulling the scope back allows
for visualization of the contralateral
mainstem bronchus at the level of the
carina. This provides a visual land-
mark when examining the subcarinal
space. Ultrasound and Doppler identi-
fication of the right and left pulmonary
artery also allows for orientation regard-
ing the anterior portion of the respec-
tive mainstem bronchus. EBUS  en-
dobronchial ultrasound.
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Endobronchial ultrasound 103igure 4 (A) Scope positioning for biopsy of a right paratracheal
station 4R) lymph node. (B) Lymph nodes are typically rounded
ith well-demarcated borders as depicted above. The needle is
arbed to allow for ultrasound visualization. (C) Standard ultra-
ound images can typically identify even small bronchial arteries
djacent to lymph nodes. Color Doppler can also be performed to
onfirm blood flow through these vessels. a.  artery; EBUS 
ndobronchial ultrasound.
104 T.D. CrabtreeFigure 5 (A) Scope positioning for bi-
opsy of a left paratracheal (station 4L)
lymph node. (B) Biopsy of a 5- to
6-mm station 4L lymph node posi-
tioned between the aortic arch and
the left main pulmonary artery. The
needle is deployed within the node.
Marks adjacent to the image indicate
centimeters for calibration of nodal
size in planning the depth of needle
insertion. EBUS  endobronchial ul-
trasound; PA  pulmonary artery.
Endobronchial ultrasound 105Figure 6 N1 nodal stations can also be accessed by EBUS. Positioning of the scope in the bronchus intermedius allows
for visualization of 11R lymph nodes most commonly identified at the junction of the right upper lobe and the
bronchus intermedius. Visualization of the carina between the right upper lobe orifice and bronchus intermedius
allows for proper orientation of the videobronchoscope for ultrasound identification of these lymph nodes. The EBUS
videobronchoscope can also be utilized to biopsy tumors adjacent to a segmental bronchus. It is often not necessary to
inflate the balloon of the scope while performing ultrasound in the segmental bronchi. EBUS  endobronchial
ultrasound.
106 T.D. CrabtreeFigure 7 Transbronchial needle aspiration device attached to the working port of the EBUS videobronchoscope. The
syringe attached is utilized to inflate the ultrasound balloon sheath with saline. A locking device at the base of the
apparatus secures the device to the working port of the scope. (Color version of figure is available online at http://
www.optechtcs.com.)
Endobronchial ultrasound 107Figure 8 (A) Once the node has been identified by ultrasound, the disposable needle aspiration device is secured to the
working port of the scope with the fastening device. It is important to hold the scope steady, maintaining nodal
visualization while the device is secured in place. This can be done by the bronchoscopist or by an assistant while the
bronchoscopist steadies the scope. Once secured, the protective sheath must be deployed by loosening the screw and
advancing the shaft of the sheath. The 22-gauge needle remains within the sheath at this time. When deployed, the
sheath must be well out of the working channel of the bronchoscope (B) and be clearly visible in the field of view of the
bronchoscope (C) to avoid needle injury to the inner channel of the scope. EBUS  endobronchial ultrasound.
108 T.D. CrabtreeFigure 9 Once the sheath is in posi-
tion, the depth of needle insertion can
be set based on ultrasound assess-
ment by adjusting the gray needle
guard. (A) Demonstrates the needle
guard set for a depth of 2 cm. This can
be set to a depth of up to 4 cm, al-
though this is rarely necessary. The
small gray clip must be removed if
one desires a depth2 cm. Once po-
sitioned, the screw of the needle
guard is secured and the needle is
ready to be engaged.
Once the needle guard is secured,
the needle is advanced with the stylet
in place (B), deploying the needle out
of the sheath (C). This requires a
sharp jab rather than a slow move-
ment to allow for penetration through
the bronchial wall. The videobron-
choscope should be held steady to
maintain visualization of the node
during needle insertion.
The stylet prevents contamination
of the needle with bronchial epithelial
cells and cartilage during passage of
the needle into the lymph node. El-
derly patients with calcified tracheal
cartilage make passage of the needle
difficult at times. Making slight ad-
justments to the position of the bron-
choscope while maintaining visual-
ization of the lymph node to avoid
penetration of the tracheal ring may
be necessary. This is more pertinent
when performing biopsies of the para-
tracheal and pretracheal lymph nodes.
Endobronchial ultrasound 109Figure 10 Once the needle has been deployed into the lymph node, the stylet is removed from the device and exchanged
for a vacuum lock syringe. With the needle visible in the node, the vacuum is applied to the needle via the stopcock.
If blood is aspirated, the needle is withdrawn and the position of the scope is adjusted. The needle is then agitated 6 to
10 times in the node with direct ultrasound visualization. Before retracting the needle from the lymph node, the
vacuum is turned off. The needle is then retracted back into the sheath and the entire device is removed from the scope
to develop the slides for analysis. Multiple aspirations per node increases the diagnostic yield and accuracy of EBUS-
TBNA.
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110 T.D. Crabtreeomments
n a prospective study of EBUS-TBNA for mediastinal staging
f lung cancer, the diagnostic accuracy rate was 96.3% in
orrectly predicting lymph node stage in 105 patients.5 In
his study, EBUS-TBNA prevented the need for mediastinos-
opy in 29 patients, thoracotomy in 8 patients, and video-
ssisted thoracoscopic surgery in 4 patients. A direct compar-
son of EBUS-TBNA, computed tomography (CT), and
ositron emission tomography (PET) was performed in 102
atients undergoing planned resection for lung cancer. The
ensitivity of CT, PET, and EBUS-TBNA for the correct diag-
osis of mediastinal and hilar lymph node staging was 76.9,
0.0, and 92.3%, respectively. The diagnostic accuracy was
0.8, 72.5, and 98%, respectively.8 The combined use of
BUS-TBNA and endoscopic ultrasound may improve the
ield compared with EBUS-TBNA alone by providing addi-
ional access to level 8 and 9 station lymph nodes.6 Currently,
ata are limited comparing mediastinoscopy and EBUS-
BNA for mediastinal lymph node staging of lung cancer. 9 In
eneral, the higher sensitivities and accuracy reported in se-
ies of patients undergoing EBUS-TBNAmay be attributed to
greater number of patients with suspicious lymph nodes by
T or PET rather than identifying occult lymph node metas-
ases in patients with a negative PET and CT. To date, there
ave been no reported major complications related to EBUS-
BNA.
Over the past 18 months, we have performed 200 EBUS-
BNA procedures at our center in patients with mediastinal
denopathy. In a cross-section of patients with mediastinal
denopathy undergoing EBUS-TBNA, 64.8% had a con-
rmed diagnosis of malignancy, 7.6% had a diagnosis of
ranulomatous disease, 19% had benign lymphoid tissue,
hereas 6.7% of the biopsies were nondiagnostic. We have
ad no complications as a result of the EBUS procedure or the
nesthesia.
It is likely that EBUS-TBNA may prevent the need for
ediastinoscopy in some patients with positive results by
BUS. The greatest concern, however, is the clinical signifi-
ance of a negative TBNA by EBUS when staging lung cancer.
he presence of micrometastatic disease in normal-sized
ymph nodes may be more likely to be missed by FNA biopsy
ompared with mediastinoscopy. This issue should be con-
idered when choosing to utilize EBUS instead of mediasti-
oscopy for routine staging.
EBUS can also be utilized for diagnosing other causes of
ediastinal adenopathy. The presence of granulomas in nee-
le biopsy specimens can assist in the diagnosis of granulo-
atous disease. Separate biopsies should be performed si-
ultaneously for culture. Utilization of EBUS for the
iagnosis of suspected lymphoma requires multiple needle
iopsies of the affected nodes to provide enough cellular
issue for flow cytometric analysis. This reemphasizes the
mportance of having an on-site cytopathologist to assist with
ssessing the adequacy of the specimen.
Other clinical situations favor the utilization of EBUS-
BNA. When used in conjunction with mediastinoscopy,
BUS-TBNA can be useful in the staging and restaging of
atients undergoing induction therapy for lung cancer.
BUS-TBNAmay be utilized as the initial procedure followed
y mediastinoscopy after induction therapy or vice versa.Weave also used EBUS-TBNA in the setting of superior vena
ava syndrome where mediastinoscopy can be hazardous or
n patients who have undergone extensive neck dissections
or head and neck tumors, limiting neck mobility and acces-
ibility necessary for mediastinoscopy. In addition to the
forementioned benefits of linear EBUS-TBNA, radial EBUS-
BNA has also been shown to improve the diagnostic yield of
iopsy of parenchymal nodules compared with standard
ronchoscopy with fluoroscopy.10 Radial endobronchial ul-
rasound is an ultrasound probe surrounded by a saline-filled
alloon that fits through the working channel of a regular size
ronchoscope. This allows for ultrasound localization of tu-
ors that cannot be visualized intrabronchially with stan-
ard video bronchoscopy. The ultrasound allows for local-
zation of these tumors to a specific bronchus for subsequent
iopsy. The biopsy is not performed in real-time with ultra-
ound as the radial probe only allows for localization. It must
hen be removed for standard biopsy techniques, unlike the
inear EBUS scope.
Regarding coding and billing for EBUS-TBNA, the current
rocedural terminology (CPT) code for bronchoscopy with
BNA is 31629. The national average physician fee for this
ode is $191.96 in a physician facility and $643.67 in a
onphysician facility. The physician fee for TBNA for each
dditional nodal station (CPT 31633) is $63.61 in a physi-
ian facility and $86.46 in a nonphysician facility. Addition-
lly, the physician fee for EBUS (CPT 31620) is $67.79 in a
hysician facility and $273.08 in a nonphysician facility.11 As
n example, a standard bronchoscopy with EBUS biopsy of
hree nodal stations would be billed as bronchoscopy with
iopsy ($195.69 for first nodal station), EBUS ($68.19), and
or each additional separate nodal station biopsy ($65.23 
) for a total of $394.34. Standard bronchoscopy combined
ith EBUS-TBNA of one nodal station generally requires ap-
roximately 10 to 20 minutes to perform with an additional
to 10 minutes/nodal station.
onclusions
BUS-TBNA is an emerging technology that is a useful ad-
unct in the evaluation of patients with or without lung can-
er with mediastinal adenopathy. The reported accuracy to
ate in select patients is favorable, although the role of EBUS
n routine staging of lung cancer remains undetermined. Me-
iastinoscopy remains the gold standard for staging of lung
ancer when performed with very low morbidity in experi-
nced hands. It is essential that thoracic surgeons play a role
n the application of EBUS for the biopsy of mediastinal
ymph nodes to maintain the same standard for lymph node
iopsy that mediastinoscopy has afforded.
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